These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16343415)

  • 1. Expression, purification, and characterization of cysteine-free mouse P-glycoprotein.
    Tombline G; Urbatsch IL; Virk N; Muharemagic A; White LB; Senior AE
    Arch Biochem Biophys; 2006 Jan; 445(1):124-8. PubMed ID: 16343415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
    Urbatsch IL; Beaudet L; Carrier I; Gros P
    Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
    Beaudet L; Urbatsch IL; Gros P
    Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of catalytic carboxylate mutants E552Q and E1197Q suggests asymmetric ATP hydrolysis by the two nucleotide-binding domains of P-glycoprotein.
    Carrier I; Julien M; Gros P
    Biochemistry; 2003 Nov; 42(44):12875-85. PubMed ID: 14596601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
    Urbatsch IL; Julien M; Carrier I; Rousseau ME; Cayrol R; Gros P
    Biochemistry; 2000 Nov; 39(46):14138-49. PubMed ID: 11087362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of N-glycosylation mutant mouse and human P-glycoproteins expressed in Pichia pastoris cells.
    Urbatsch IL; Wilke-Mounts S; Gimi K; Senior AE
    Arch Biochem Biophys; 2001 Apr; 388(1):171-7. PubMed ID: 11361134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins.
    Lerner-Marmarosh N; Gimi K; Urbatsch IL; Gros P; Senior AE
    J Biol Chem; 1999 Dec; 274(49):34711-8. PubMed ID: 10574938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.
    Julien M; Gros P
    Biochemistry; 2000 Apr; 39(15):4559-68. PubMed ID: 10758006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of conserved aromatic residues in the A-loop of the ABC transporter ABCB1A (mouse Mdr3).
    Carrier I; Urbatsch IL; Senior AE; Gros P
    FEBS Lett; 2007 Jan; 581(2):301-8. PubMed ID: 17214987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein.
    Urbatsch IL; Gimi K; Wilke-Mounts S; Senior AE
    Biochemistry; 2000 Oct; 39(39):11921-7. PubMed ID: 11009605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of the ABC signature sequences in the human multidrug resistance protein 1.
    Ren XQ; Furukawa T; Haraguchi M; Sumizawa T; Aoki S; Kobayashi M; Akiyama S
    Mol Pharmacol; 2004 Jun; 65(6):1536-42. PubMed ID: 15155846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
    Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
    Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple purification of highly active biotinylated P-glycoprotein: enantiomer-specific modulation of drug-stimulated ATPase activity.
    Julien M; Kajiji S; Kaback RH; Gros P
    Biochemistry; 2000 Jan; 39(1):75-85. PubMed ID: 10625481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette.
    Kim IW; Peng XH; Sauna ZE; FitzGerald PC; Xia D; Müller M; Nandigama K; Ambudkar SV
    Biochemistry; 2006 Jun; 45(24):7605-16. PubMed ID: 16768456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
    Ernest S; Bello-Reuss E
    Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
    Rao US
    Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.
    Stephens RH; O'Neill CA; Bennett J; Humphrey M; Henry B; Rowland M; Warhurst G
    Br J Pharmacol; 2002 Apr; 135(8):2038-46. PubMed ID: 11959808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
    Urbatsch IL; Sankaran B; Weber J; Senior AE
    J Biol Chem; 1995 Aug; 270(33):19383-90. PubMed ID: 7642618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra.
    Cao J; Chen X; Liang J; Yu XQ; Xu AL; Chan E; Wei D; Huang M; Wen JY; Yu XY; Li XT; Sheu FS; Zhou SF
    Drug Metab Dispos; 2007 Apr; 35(4):539-53. PubMed ID: 17220245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.